HDAC9 and arthritic joint disease: HDAC inhibitors have been studied with respect to their potential use as topical treatments, with a view to developing a means for rapid penetration into the skin for the treatment of melanoma and arthritis (for example, Chung et al., 2004, Gowda et al., 2012).